BC Platforms recognized among TIME’s World’s Top HealthTech Companies 2026
BC Platforms has been recognized among TIME’s World’s Top HealthTech Companies 2026 in AI & Data Analytics for the second consecutive year.
BC Catalyst: Your research starts here
BC Catalyst is our AI-native life sciences intelligence platform connecting proprietary patient data, scientific knowledge, clinical intelligence, and advanced analytics in one decision-support environment.
Connected insights at global scale
Research teams often have to piece together information from separate sources before they can decide where to focus. BC Catalyst brings that context together, helping teams assess opportunities and identify the questions that warrant deeper investigation.
AI-native intelligence for life sciences
Explore connected patient, biomarker, cohort, trial, and disease intelligence through focused capabilities designed for pharmaceutical and biotech teams.
Explore disease areas using conversational prompts to surface scientific, clinical, and BC Platforms patient intelligence.
Identify relevant biomarkers, pathways, and therapeutic opportunities.
Define and segment patient populations using clinical, demographic, and molecular characteristics.
Examine global trial activity and benchmark sponsors, biomarkers, and competitive trends.
Query real-world disease distribution to identify clinical opportunities and inform site selection.
Why choose BC Catalyst?
Patient context beyond public sources
Bring proprietary patient intelligence into your research alongside scientific and trial information, including aggregated patient counts not available through public trial databases.
Explore without the manual legwork
Use conversational prompts to investigate research questions without manually piecing together information from separate sources.
Insights you can interpret and share
Compare findings through AI-assisted summaries and visual outputs, giving colleagues a clearer basis for discussion.
A route to deeper evidence
Identify where to focus next through early exploration, then progress to deeper evidence generation and advanced analytics with BC Platforms.
Questions that guide your next decision
Start with the research or planning decision you need to make.
Discovery research
Which biomarkers and pathways warrant further investigation in this disease area?
Trial planning
How do the clinical, demographic, and molecular criteria we are considering shape the patient population?
Competitive insight
Which sponsors and trials are active in this indication, and which biomarkers are they studying?
Evidence generation
Where does available patient coverage suggest a useful starting point for deeper feasibility or evidence-generation work?
Built on a powerful foundation
BC Catalyst draws on genomic and patient data, AI-native technology, and BC Platforms domain expertise. BC Unify, our data mastering platform, harmonizes and prepares the underlying data for exploration and analysis.
Certified for quality, security, and trust
BC Platforms meets the highest international standards for data protection, product quality, and ethical data governance. Our ISO-certified systems and compliance frameworks protect every stage of the data lifecycle, ensuring partners can innovate confidently and responsibly.
Featured news and insights
-
Read more
-
BC Platforms supports national pathway for cancer vaccine trials
Read moreBC Platforms co-developed the Cancer Vaccine Launch Pad’s central referral tool, supporting a national pathway to cancer vaccine clinical trials.
-
Beyond AI predictions: Building a continuous learning system for drug discovery
Read moreExplore how trusted Lab-in-the-Loop systems connect AI, laboratory experimentation and scientific evidence to improve drug-discovery decisions.